Patents by Inventor Eric Rubinstein

Eric Rubinstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for cancer management targeting Co-029
    Patent number: 9487586
    Abstract: The present disclosure relates to a Co-029 inhibitor for inhibiting the migration of cancer cells which express Co-029. The disclosure relates to a Co-029 inhibitor for the treatment of cancer and/or the prevention of cancer metastasis and pharmaceutical compositions comprising said inhibitor and provides Co-029 antibodies. The disclosure provides a method for predicting the response of a patient afflicted with or susceptible to be afflicted with cancer to a medical treatment with a Co-029 inhibitor, a method for diagnosing a cancer in a patient and a method for predicting the survival in a cancer patient.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: November 8, 2016
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), UNIVERSITE DE PARIS XI PARIS SUD
    Inventors: Eric Rubinstein, Céline Greco, François Le Naour, Claude Boucheix
  • METHODS FOR CANCER MANAGEMENT TARGETING CO-029
    Publication number: 20150291691
    Abstract: The present disclosure relates to a Co-029 inhibitor for inhibiting the migration of cancer cells which express Co-029. The disclosure relates to a Co-029 inhibitor for the treatment of cancer and/or the prevention of cancer metastasis and pharmaceutical compositions comprising said inhibitor and provides Co-029 antibodies. The disclosure provides a method for predicting the response of a patient afflicted with or susceptible to be afflicted with cancer to a medical treatment with a Co-029 inhibitor, a method for diagnosing a cancer in a patient and a method for predicting the survival in a cancer patient.
    Type: Application
    Filed: April 21, 2015
    Publication date: October 15, 2015
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), UNIVERSITE DE PARIS XI PARIS SUD
    Inventors: Eric RUBINSTEIN, Céline GRECO, François LE NAOUR, Claude BOUCHEIX
  • Methods for cancer management targeting Co-029
    Patent number: 9040671
    Abstract: The present disclosure relates to a Co-029 inhibitor for inhibiting the migration of cancer cells which express Co-029. The disclosure relates to a Co-029 inhibitor for the treatment of cancer and/or the prevention of cancer metastasis and pharmaceutical compositions comprising said inhibitor and provides Co-029 antibodies. The disclosure provides a method for predicting the response of a patient afflicted with or susceptible to be afflicted with cancer to a medical treatment with a Co-029 inhibitor, a method for diagnosing a cancer in a patient and a method for predicting the survival in a cancer patient.
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: May 26, 2015
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Paris X1 Paris Sud
    Inventors: Eric Rubinstein, Céline Greco, François Le Naour, Claude Boucheix
  • METHODS FOR CANCER MANAGEMENT TARGETING CO-029
    Publication number: 20130122002
    Abstract: The present disclosure relates to a Co-029 inhibitor for inhibiting the migration of cancer cells which express Co-029. The disclosure relates to a Co-029 inhibitor for the treatment of cancer and/or the prevention of cancer metastasis and pharmaceutical compositions comprising said inhibitor and provides Co-029 antibodies. The disclosure provides a method for predicting the response of a patient afflicted with or susceptible to be afflicted with cancer to a medical treatment with a Co-029 inhibitor, a method for diagnosing a cancer in a patient and a method for predicting the survival in a cancer patient.
    Type: Application
    Filed: July 22, 2011
    Publication date: May 16, 2013
    Applicant: Insitutut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Eric Rubinstein, Céline Greco, François Le Naour, Claude Boucheix